Skip to main content
Nephron Pharmaceuticals Continues Production Despite Hurricane Florence September 13, 2018

West Columbia, S.C. (September 13, 2018) – Nephron Pharmaceuticals Corporation is currently producing medications at its West Columbia, S.C.  facility while monitoring the effects of Hurricane Florence.

The hurricane is projected to reach South Carolina late Thursday evening; however Nephron will remain open for business in order to continuously produce drug shortage medications. Products including Saline, Sodium Bicarbonate, and controlled substances are readily available to be ordered.

“We saw first-hand the emergency hurricanes can cause on the drug shortage crisis after hurricane season in 2017,” said Lou Kennedy, Nephron CEO. “We want people to know that we are continuing to work, to ensure we provide hospitals with the products they desperately need.”

The state-of-the-art facility was built to withstand natural disasters such as hurricanes. The 408,000 square foot building is equipped with backup generators ready to take over within seconds if power is lost. Additionally, Nephron is conveniently located next to South Carolina Electric and Gas Company, allowing for immediate assistance if necessary.

Hospitals and surgery centers may contact Nephron toll free at 844-244-2225, or via email at customerservice@nephronpharm.com.


About Nephron
Nephron 503B Outsourcing is a division of Nephron Pharmaceuticals Corporation. This division produces pre-filled sterile syringes and IV bags for hospitals across America, in an effort to alleviate their drug shortage needs. In accordance with the DQSA draft guidance, the company follows cGMP, GDP and all quality expectations. The company has been licensed by the Food and Drug Administration as a sterile manufacturer of generic respiratory medications along with an Outsourcing Facility providing equal sterility and quality. Nephron received a 2017 ISPE/FOYA innovation award for the high level of automation present throughout the facility. For more information, please visit www.nephronpharm.com.